This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Genaera Corporation. Active years: 2001-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2010
Title: Innovations of U Prasad Kari in Asthma Research
Introduction
U Prasad Kari, a notable inventor based in Hatfield, PA, has made significant contributions in the field of biotechnology, particularly in asthma research. With a portfolio of four patents, his work has focused on innovative peptides that potentially alter the understanding of allergic responses related to asthma.
Latest Patents
Among his latest patents, U Prasad Kari has developed interleukin-9 mutein peptides. These innovations stem from a C to T DNA variation at position 3365 in exon 5 of the human Asthma Associated Factor 1 (AAF1). This genetic alteration leads to a critical amino acid substitution where methionine replaces threonine at codon 117 of AAF1. Intriguingly, when this substitution occurs in both alleles of an individual, it corresponds with a reduced likelihood of atopic allergies, including asthma. Furthermore, it is associated with fewer abnormal skin test responses and a lower serum total IgE. Through his research, Kari has identified a unique non-asthmatic, non-atopic phenotype characterized by the methionine at codon 117 when it manifests in both AAF1 gene products.
Career Highlights
U Prasad Kari's career has seen him grow as a key figure at Genaera Corporation, where he has applied his expertise in genetic research and biotechnology. His work not only pushes boundaries in academic thought but also translates into innovative solutions for treating asthma and related conditions.
Collaborations
Throughout his career, Kari has worked closely with accomplished colleagues such as Roy Clifford Levitt and W Lee Maloy. These collaborations have enriched his research outcomes and facilitated the sharing of knowledge, further enhancing the impact of his inventions.
Conclusion
In conclusion, U Prasad Kari stands out as an influential inventor whose work on interleukin-9 mutein peptides is paving the way for new approaches in understanding asthma and allergies. His dedication to research at Genaera Corporation and fruitful collaborations underline the importance of innovation in the medical field, ultimately contributing to better health outcomes for individuals affected by asthma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile